Medical Weight Loss
US$ 27.90
glp-1 companion BODY BALANCE Capsules - 60-count GLP-1 Companion – StayWell
Description
Learn of GLP-1 agonist drugs and weight loss pills for diabetes type 2, along with alternative supplements and lifestyle changes
Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027
GLP-1 and GIP receptor agonists are groundbreaking treatments originally developed for diabetes, now also employed in managing obesity
The current report aims to present an overview of current knowledge on GLP-1 RAs based on pragmatic review of the available clinical evidence
